# Enzymecode

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/enzymecode

- Industry: Forestry & Timber
- Headquarters: Tianjin, China
- Website: www.enzymecode.com
- Latest round: Angel (Dec 29, 2023)
- Investors on record: 1

## About

Established in 2017 and based in Tianjin, China, Enzymecode is a synthetic bio-enterprise that lays out the functional raw material for brain health, phosphatidylserine. The company owns the core platform technologies of synthetic biology and microchannel reactor fluid chemistry, and has built its own 3200 square meters factory with 100,000 grade clean room. In December 2023, it closed a round of angel funding.

The company has developed phosphatidylserine enzyme-catalyzed green processing technology to produce phosphatidylserine-based nutritional raw materials and food ingredients, including phosphatidylserine extracted from non-GMO soybeans and non-GMO sunflower seeds in different purities, powders, and oils, as well as services and products like high-pressure jet nano-micron pulverization systems, aflatoxin adsorption and removal agents, etc. The company also provides space food such as PS chocolate for Chinese astronauts.

The company will use the angel funding raised in December 2023 to advance the global commercialization of phosphatidylserine and the industrialization of several other synthetic biology products under development.

## Funding rounds

- Angel, Dec 29, 2023 — DFJ DragonFund China

## Investors

- DFJ DragonFund China (https://capitalatlas.ai/funds/dfj-dragonfund-china) — Angel